High-dose Intensity-modulated proton therapy versus Standard-dose Intensity-modulated RadIation therapy for esophageal squamous cell carcinoma (HI-SIRI): study protocol for a randomized controlled clinical trial
DiscussionThis randomized clinical trial will demonstrate the clinical benefit of IMPT in esophageal cancer treatment in terms of survival and toxicity outcomes which will further establish high-level evidence for radiation modality in squamous cell carcinoma of the thoracic esophagus.Trial registrationTCTR20200310006. Registered 10 March 2020. (Source: Trials)
Source: Trials - October 22, 2022 Category: Research Source Type: clinical trials

Varian ProBeam Proton Therapy System China Clinical Trial (Hefei)
Condition:   Tumors Intervention:   Radiation: Proton Therapy System (ProBeam) Sponsor:   Varian, a Siemens Healthineers Company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 18, 2022 Category: Research Source Type: clinical trials

Feasibility of Patient Selection and Treatment of Head-neck Cancer With Proton Therapy in Denmark
Condition:   Head-and-neck Cancer Intervention:   Other: Proton radiotherapy Sponsor:   Danish Head and Neck Cancer Group Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 21, 2022 Category: Research Source Type: clinical trials